CCS Cell Culture Service Signs Strategic License Agreement with CEVEC Pharmaceuticals
News Nov 05, 2012
The transient CAP-TTM protein production technology is based on CAP® cells, an immortalized cell line for stable protein production developed by CEVEC. These non-tumor origin cell lines exhibit high protein expression, have been adapted to serum-free suspension culture and show post-translational modifications that are human-like, including authentic human glycosylation patterns.
The collaboration combines CEVEC's proprietary CAP-TTM expression system with CCS' expertise to produce and process bulk quantities of transiently transfected cells for drug discovery research in pharmaceutical companies worldwide.
"CCS Cell Culture Services is a very experienced and trusted partner for the custom supply of cell based assay reagents. We're very pleased that they will add our CAP-T cells to their cell based assay technology portfolio and we're convinced that the cells will contribute significantly to the drug discovery process in the pharma industry " stated Wolfgang Kintzel, CEO at CEVEC.
Oliver Wehmeier, Managing Director of Cell Culture Services said: "We are excited about the potential of CEVEC's CAP-T technology. The cells meet all requirements for a host cell line in terms of robustness, transfection efficacy, expression level, and scalability. We obtained outstanding results from transient transfections of various secreted, intracellular, or membrane bound target proteins in CAP-T cells and we are pretty sure that this expression system will be of great benefit to our customers"
One in Five Materials Chemistry Papers May be Wrong, Study SuggestsNews
The replicability of results from scientific studies has become a major source of concern in the research community, particularly in the social sciences and biomedical sciences. A new study that compared the results reported in thousands of papers published about the properties of metal organic framework (MOF) materials – which are prominent candidates for carbon dioxide adsorption and other separations – suggests the replicability problem should be a concern for materials researchers, too.READ MORE
Nanodiscs Catch Misfolding Proteins Red-HandedNews
When proteins misfold, accumulate and clump around insulin-producing cells in the pancreas, they kill cells. Now, researchers have obtained a structural snapshot of these proteins when they are most toxic, detailing them down to the atomic level.READ MORE